apalutamide: Clinical Trials

5 trials of apalutamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5

Follow apalutamide: new trials by email Literature Review of apalutamide trials Research Report on apalutamide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
Apalutamide, Biopsy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma
Phase 2TerminatedUniversity of Washington82024-05-232026-10-19
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
Apalutamide, Cetrelimab - Small Cell Neuroendocrine Carcinoma, Prostate Cancer
Phase 2TerminatedRahul Aggarwal22022-03-162025-05-15
Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer
Abiraterone Acetate, Apalutamide, Prednisone - Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation
Phase 2TerminatedM.D. Anderson Cancer Center72018-03-062026-03-16
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment - Prostate Adenocarcinoma
Phase 2TerminatedUniversity of Washington242017-11-022023-02-09
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
Leuprolide Acetate, Prednisone, Docetaxel - Prostate Cancer
Phase 2TerminatedDana-Farber Cancer Institute92017-06-232020-04-09

Conditions studied

Prostatic Neoplasms (4)  ·  Bulbo-Spinal Atrophy, X-Linked (1)  ·  Carcinoma, Small Cell (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

University of Washington (2)  ·  Dana-Farber Cancer Institute (1)  ·  M.D. Anderson Cancer Center (1)  ·  Rahul Aggarwal (1)

Countries

United States (5)

Top investigators

Bagi Jana, MD (1)  ·  Lauren C Harshman, MD (1)  ·  Michael Schweizer (1)  ·  Rahul Aggarwal, MD (1)  ·  Ruben Raychaudhuri, MD (1)

NIH funding

P30CA015704 (1)